ライフサイエンスコーパス: OR

1 OR of sarcopenic obesity were higher for men 2.17 (1.70-

2 OR, CR and OS rates by day 100 were 86.7, 53.3 and 86.7%

3 07, P < .001) and MSP1 (OR, 2.41, P = .0006; OR, 5.78, P < .001), respectively.

4 rease in CR-POPF (10.7% vs 35.5%, P < 0.001; OR 0.20, 95% confidence interval 0.12-0.33).

5 ely in areas further from cities (p < 0.001; OR = 0.66) and with higher forest coverage (p < 0.001; O

6 and with higher forest coverage (p < 0.001; OR = 0.70).

7 1.23) and high cropland coverage (p < 0.001; OR = 0.80).

8 gh average monthly precipitation (p < 0.001; OR = 1.14), and high surface runoff (p < 0.001; OR = 1.3

9 ociated with low forest coverage (p < 0.001; OR = 1.23) and high cropland coverage (p < 0.001; OR = 0

10 ted with high population density (p < 0.001; OR = 1.27), high cropland coverage (p < 0.001; OR = 1.47

11 = 1.14), and high surface runoff (p < 0.001; OR = 1.37), while low groundwater contamination was more

12 with higher weekly precipitation (p < 0.001; OR = 1.44) and higher livestock density (p = 0.05; OR =

13 = 1.27), high cropland coverage (p < 0.001; OR = 1.47), high average monthly precipitation (p < 0.00

14 ls to AMA1 (odds ratio [OR], 2.41, P < .001; OR, 2.07, P < .001) and MSP1 (OR, 2.41, P = .0006; OR, 5

15 d RFI between baseline to week 20, P = .005, OR 10.2, 95% CI 2.1 to 51.3) were both significant predi

16 cantly associated with mortality (P = 0.007; OR, 6.91; 95% CI, 1.68-28.48) and ICU admission (P = 0.0

17 I, 1.68-28.48) and ICU admission (P = 0.007; OR, 7.93; 95% CI, 1.75-35.69) in LT recipients.

18 who became negative (23.8% vs 9.8%, p=0.01; OR 2.15, 95%CI 1.17-3.95).

19 ho remained negative (21.8% vs 8.5%, p=0.01; OR 3.0, 95%CI 1.31-6.87).

20 18% versus 30.2% after 24 months (P = 0.04, OR 3.47).

21 .44) and higher livestock density (p = 0.05; OR = 1.11), while low contamination was associated with

22 y due to logistical reasons (3.0% vs. 19.1%, OR=0.13 95% CI 0.04-0.37) and to show inconclusive resul

23 rsus 2.4%, OR, 2.36; CTA: 23.4% versus 4.1%, OR, 6.49; P<0.001), and composite outcomes were higher f

24 ad higher LV stiffness indices (>0.11 ml(-1) OR 3.067, 95% CI 1.825-5.128, p < 0.001).

25 NASH (ADH1B*2: OR, 0.80; P < .01 vs ADH1B*1: OR, 0.96; P = .036) and a reduced risk of an NAFLD activ

26 her (ADH1B*2: OR, 0.83; P = .012 vs ADH1B*1: OR, 0.96; P = .048) (P < .01 for the difference in the e

27 R] = 2.02; P = 0.003), number of teeth <=14 (OR = 1.78; P = 0.034), and smoking (OR = 2.19; P = 0.001

28 ntermediate featuring a unique Ni(2)(OR)(2) (OR = alkoxide) diamond-like core complemented by a mu-io

29 i(III) intermediate featuring a unique Ni(2)(OR)(2) (OR = alkoxide) diamond-like core complemented by

30 th a reduced risk of definite NASH (ADH1B*2: OR, 0.80; P < .01 vs ADH1B*1: OR, 0.96; P = .036) and a

31 AFLD activity score of 4 or higher (ADH1B*2: OR, 0.83; P = .012 vs ADH1B*1: OR, 0.96; P = .048) (P <

32 We identified 220 OR open reading frames, 20 of which are full length, int

33 = 3.70 * 10(-3)) but positively with IA-2A (OR 1.64; P = 2.40 * 10(-14)), despite a single differenc

34 rates (FLR <=30%: 14.3% vs FLR >30%: 14.3%; OR 1.17, 95% CI 0.33-4.10).

35 d compared to sigmoidoscopy at 1.4% vs 2.4% (OR, 0.57; 95% CI, 0.53-0.62) but higher after 3 cumulati

36 ter 3 cumulative FIT rounds at 2.7% vs 2.4% (OR, 1.14; 95% CI, 1.05-1.23).

37 3.01 to 8.46]; for males, 16.5% versus 9.4% [OR = 1.91; 95% CI = 1.20 to 3.02]).

38 d catheterization (stress: 5.5% versus 2.4%, OR, 2.36; CTA: 23.4% versus 4.1%, OR, 6.49; P<0.001), an

39 ds ratio [OR], 1.91; CTA: 36.5% versus 8.4%, OR, 5.95; P<0.001) and catheterization (stress: 5.5% ver

40 the odds of hyperuricemia increased by 44% (OR=1.44; 95% CI: 1.13, 1.84) in the 2-6 servings/wk grou

41 A and OA for 90-day mortality (7.2% vs 8.5%, OR 0.80, 95% CI 0.56-1.15, P = 0.23), median LOS (equiva

42 95% CI, 1.75-4.36) and human herpes virus 6 (OR, 3.50; 95% CI, 1.15-10.63) were detected more frequen

43 4) in the 2-6 servings/wk group, and by 89% (OR=1.89; 95% CI: 1.39, 2.57) in the >=7 servings/wk cate

44 show inconclusive results (11.1% vs. 42.9%, OR=0.17 95% CI 0.08-0.33).

45 Adenovirus (OR, 2.67; 95% CI, 1.75-4.36) and human herpes virus 6 (O

46 to be admitted for unstable angina (adjusted OR, 1.46 [95% CI, 1.04-2.05]).

47 ded a significant emotional burden (adjusted OR 2.22, 95% CI 1.49 to 3.31).

48 10(-22)) and replication datasets (adjusted OR = 1.55, P = 0.06) with a loss-of-function mutation, Q

49 bserve an association in discovery (adjusted OR = 2.61, P = 7.98 x 10(-22)) and replication datasets

50 Adjusted ORs for the impact of dry eye were generally lower than

51 2.7; 95% CI, 1.3-5.6), and CRP on admission (OR, 1.006; 95% CI, 1.001-1.01).

52 (OR, 9.8 [95% CI, 2.3-41.0]; AFE, 90%), AdV (OR, not available; AFE, approximately 100%), RV (OR, 7.1

53 Older age (OR-1.07), grade B/C pancreatic fistula (OR-3.84), and ep

54 l heart rate and dual antiviral therapy, age(OR 1.06, 95% C.I. 1.00-1.13, p<0.05), basal heart rate(O

55 n (>=81 years of age vs. 66-70 years of age: OR, 0.49; 95% confidence interval [CI], 0.48-0.50), wher

56 in the highest quartile (>=358 pg/mL) had an OR for VTE of 2.05 (95% confidence interval, 1.37-3.08)

57 In this study, we investigated an OR(His) variant of Arabidopsis OR, genetically mimicking

58 nce of major fractures in adjusted analyses (OR, 1.0; 95% CI, 0.5-1.8).

59 of the first ever documented Thermal AND and OR logic gates.

60 d in the meta-analysis, stratified by HR and OR.

61 for 150 mg S44819 compared with placebo and OR 1.17 [95% CI 0.81-1.67]; p=0.80 for 300 mg S44819 com

62 re, we describe the design of two-input AND, OR, NAND, NOR, XNOR, and NOT gates built from de novo-de

63 ), adverse events due to decreased appetite (OR 3.56, 95% CI: 1.94-6.53), diarrhoea (OR 2.61, 95% CI:

64 Although drugs of misuse appropriate ORs, conflicting reports indicate immunostimulatory and

65 vestigated an OR(His) variant of Arabidopsis OR, genetically mimicking the melon OR(His) allele, and

66 1.32-3.73)) and living in a more rural area (OR = 1.38(1.01-1.89)) are strongly associated with immun

67 dog was dead at the time of the assessment (OR = 20.7, 95% CI 6.7-63.7).

68 9 x 10-6), and large artery atherosclerosis (OR = 2.4, 95% CI, 1.41-4.07, P value = 0.003).

69 CI 0.83-0.98; p = 0.011) and in UK Biobank (OR 0.90; 95% CI 0.80-1.02; p = 0.104), but the associati

70 0.006), CFI (OR = 4.45; P = 0.005), and C3 (OR = 6.56; P = 0.0003) genes was observed in late AMD pa

71 0.85, 0.98) compared with those without CAD (OR 1.01; 95% CI 0.99, 1.03) and heterogeneity P = 0.0041

72 Interval [CI] 3.50-7.61) and kidney cancer (OR 2.50; 95% CI 1.69-3.72).

73 ng, breast, colorectal, or prostate cancers (OR range 0.78-1.10; P >= 0.27 for >= 2 versus < 1 times/

74 Low values of cholesterol efflux capacity (OR(1SD), 0.33; 95% CI, 0.18-0.61), sphingosine-1-phospha

75 was aged >=20 years had higher risks of CD (OR = 1.22, 95% CI: 1.01, 1.49) and UC (OR = 1.15, 95% CI

76 after pancreatectomy in low volume centers (OR = 3.76, CI95%[2.83; 5.01], P < 0.001) were associated

77 FH (odds ratio [OR] = 2.88; P = 0.006), CFI (OR = 4.45; P = 0.005), and C3 (OR = 6.56; P = 0.0003) ge

78 CI, 1.43, 2.37, P value = 2.0 x 10-6), CHD (OR = 1.64, 95% CI, 1.28-2.09, P value = 8.07 x 10-5), he

79 associated with exposure to young children (OR:2.71, 95%CI 1.51-5.02, p<0.001), and among asymptomat

80 = 0.85-0.99; p = 0.03) and LDL cholesterol (OR = 0.88; 95% CI = 0.81-0.95; p = 0.002) were inversely

81 e, 20-100%) increased risk of developing CL (OR, 1.5; 95% CI, 1.2-2.0; P = .0004).

82 CI, 1.19 to 1.57), pulmonary complications (OR, 1.50; 95% CI, 1.29 to 1.74), reoperations (OR, 1.74;

83 sociated with increased total complications (OR, 1.36; 95% CI, 1.19 to 1.57), pulmonary complications

84 ciated Alterations in the Genome consortium (OR 0.90; 95% CI 0.83-0.98; p = 0.011) and in UK Biobank

85 atio [OR], 6.5; P = 0.01), a recent contact (OR, 2.3; P = 0.02), and testing for surveillance (OR, 2.

86 d in 20% of SOTr compared to 4% of controls (OR 6 CI [1.64-22] P = .007).

87 , 7.1 [95% CI, 3.7-13.6]; AFE, 86%) and CoV (OR, 2.8 [95% CI, 2.0-4.1]; AFE, 65%) in older adults pre

88 e of recurrent ischemic events (vs >14 days; OR = 0.76, 95% CI = 0.36-1.62, p = 0.482).

89 eals stronger instrumental estimates of DBP (OR [95% CI] = 1.20 [1.15-1.25]/10 mmHg; P = 5.57 x 10(-2

90 een the CAD PRS and risk of all-cause death (OR 0.91; 95% CI 0.85, 0.98) compared with those without

91 LFL and PL were associated with death (OR 13.20, 95%CI 5.21-33.78 and 8.58, 2.56-29.08 respecti

92 tis was higher in individuals with diabetes (OR (highest vs. lowest quartile of FLI), 2.89; 95% CI, 1

93 ite (OR 3.56, 95% CI: 1.94-6.53), diarrhoea (OR 2.61, 95% CI: 1.46-4.67), somnolence (OR 2.23, 95% CI

94 y sick visits within 12 months of discharge (OR = 5.8).

95 I]: 0.39, 0.91), experienced discrimination (OR: 0.62, 95% CI: 0.41, 0.95), and perceived racism (OR:

96 .2-3.4, P = 0.009), coronary artery disease (OR, 1.9; 95% CI, 1.1-3.7; P = 0.04), and respiratory fai

97 % CI 1.12-1.34) and ischaemic heart disease (OR 1.30, 95% CI 1.15-1.47).

98 7.57), cytomegalovirus infection or disease (OR = 2.67; 95% CI = 1.12-6.32), and acute graft rejectio

99 er disease, including biliary stone disease (OR, 4.06; CI, 2.24-7.36; P < 0.001), was the only signif

100 ion compared with those not taking the drug (OR 0.70, 95%CI 0.55-0.88).

101 times more likely to be referred to the ED (OR 6.46, 95% CI 4.63-9.01).

102 GCSE O-levels, compared to higher education (OR = 3.94; 95%CI: 2.74, 5.67), after adjusting for other

103 of coughing in the source case at enrolment (OR 1.6; 95% CI: 1.1-2.3).

104 stic regression models were used to estimate ORs and 95% CIs among cases (556 hyperplastic polyp, 175

105 .37, 95% CI: 1.17-24.65), any adverse event (OR 1.55, 95% CI: 1.03-2.33), adverse events due to decre

106 % CI: 1.04-6.80), any serious adverse event (OR 2.30, 95% CI: 1.18-4.48), serious adverse events rela

107 95% CI: 1.38-4.96) or due to adverse events (OR 2.65, 95% CI: 1.04-6.80), any serious adverse event (

108 1.1-3.7; P = 0.04), and respiratory failure (OR, 4.7; 95% CI, 1.1-26.3; P = 0.049).

109 f CRC with the traditional pathway features (OR per 5 kg/m2: 1.73; 95% CI: 1.28, 2.34; Pheterogeneity

110 t for asymptomatic individuals (for females, OR = 1.53 [95% CI = 1.09 to 2.14]; for males, OR = 1.42

111 ulin (OR = 3.71, CI = 1.21-11.33), ferritin (OR = 4.20, CI = 1.40-12.65), and serum amyloid P (OR = 3

112 age (OR-1.07), grade B/C pancreatic fistula (OR-3.84), and epidural use (OR-3.12) were independently

113 (OR, 8.5 [95% CI, 3.9-18.5]; AFE, 88%), Flu (OR, 8.3 [95% CI, 4.4-15.9]; AFE, 88%), PIV (OR, not avai

114 (OR=3.14, 95% CI 1.09 to 8.99) and MND-FTD (OR=5.08, 95% CI 1.26 to 20.40).

115 ntly associated with delayed graft function (OR, 1.16; 95% CI, 0.94-1.43; P = 0.16), estimated glomer

116 QAD was negatively associated with GADA (OR 0.88; P = 3.70 * 10(-3)) but positively with IA-2A (O

117 sitting had 58% decreased odds of glaucoma (OR, 0.42; 95% CI, 0.25-0.70).

118 spectroscopy OR MRS) AND (glutamate OR glut* OR GLX) AND (schizophrenia OR psychosis OR schizophren*)

119 esonance spectroscopy OR MRS) AND (glutamate OR glut* OR GLX) AND (schizophrenia OR psychosis OR schi

120 the two S44819 groups and the placebo group (OR 0.91 [95% CI 0.64-1.31]; p=0.80 for 150 mg S44819 com

121 day for men was combined with smoking habit (OR = 7.30 [95% CI: 6.1-8.73]).

122 a higher risk of intracerebral haemorrhage (OR: 1.64, 95% CI = 1.26-2.13).

123 ith dysglycemia but none outperformed HbA1c (OR = 4.09 [2.81-5.94]).

124 P value = 8.07 x 10-5), heart failure (HF) (OR = 1.61, 95% CI, 1.32-1.95, P value = 1.9 x 10-6), and

125 t available; AFE, approximately 100%), HMPV (OR, 9.8 [95% CI, 2.3-41.0]; AFE, 90%), AdV (OR, not avai

126 sociated with death or discharge to hospice (OR, 1.14; P = 0.044), controlling for age, body mass ind

127 2.0), oxygen requirement at hospitalization (OR, 2.9; 95% CI, 1.3-6.7), acute renal injury (OR, 2.7;

128 , P = 0.045) or Magnet designated hospitals (OR 0.45, 95% CI 0.29-0.71, P = 0.001).

129 asure if treated at nonsafety net hospitals (OR 0.62, 95% CI 0.39-0.99, P = 0.045) or Magnet designat

130 date, surprisingly little is known about how OR antagonism shapes neuronal representations in the det

131 was significantly associated with prior HTN (OR 1.31, 95% CI 1.29-1.33) after adjusting for age, sex,

132 ated when the dog displayed hypersalivation (OR = 34.6, 95% CI 11.3-106.5) or paralysis (OR = 19.0, 9

133 95% CI: 0.40-0.89), and apolipoprotein A-I (OR(1SD), 0.59; 95% CI, 0.37-0.93) were particularly link

134 ssociated with an ultimate diagnosis of IBS (OR 5, p < 0.02).

135 = 0.002], pain on exertion [EHS I vs EHS II: OR = 1.342 (1.223-1.473), P < 0.001; EHS I vs EHS III an

136 d pain requiring treatment [EHS I vs EHS II: OR = 1.594 (1.357-1.874), P < 0.001; EHS I vs EHS III an

137 n was associated with reduced STI incidence (OR, 0.66 [95% CI, 0.54-0.81; I2 = 74%]).

138 n IA and posttransplant bacterial infection (OR = 7.51; 95% CI = 4.37-12.91), respiratory tract viral

139 EBV/KSHV co-infection (OR = 5.71(1.58-7.12)), HIV positivity (OR = 2.22(1.32-3.

140 in susceptibility to any H1N1pdm infection (OR: 1.20, 95%CI: 0.62-2.34).

141 trols with presence of rhinovirus infection (OR:4.23; 95%CI 1.16-14.22, p<0.05).

142 7-12.91), respiratory tract viral infection (OR = 7.75; 95% CI = 1.60-37.57), cytomegalovirus infecti

143 Hepatitis C virus infection (OR, 15.84; 95% confidence interval [CI], 4.06-61.87; P <

144 anges were observed for stimulant injecting (OR, 0.98; 95% CI, 0.94-1.02) or alcohol use (OR, 0.99; 9

145 , 2.9; 95% CI, 1.3-6.7), acute renal injury (OR, 2.7; 95% CI, 1.3-5.6), and CRP on admission (OR, 1.0

146 roach enables ready extension to three-input OR, AND, and disjunctive normal form gates.

147 frames, 20 of which are full length, intact OR genes, and found a large ratio of partial and pseudog

148 e ratio of partial and pseudogenes to intact OR genes (2:1), suggestive of a dynamic mode of evolutio

149 of smoking on oral/oropharyngeal cancer (IVW OR 2.6, 95% CI = 1.7, 3.9 per standard deviation increas

150 onsumption when controlling for smoking (IVW OR 2.1, 95% CI = 1.1, 3.8 per standard deviation increas

151 0.137, P = .004) and need for keratoplasty (OR 0.093, P = .003) favored alloSLET over AMG.

152 .01-2.33) and low apolipoprotein A-I levels (OR(1SD), 0.52; 95% CI, 0.31-0.88) were associated with u

153 Similarly, the lower occurrence of LSCD (OR 0.137, P = .004) and need for keratoplasty (OR 0.093,

154 men were more likely than men to receive LT (OR, 1.42; 95% CI, 1.39-1.45).

155 nteraction with ERCC8 (joint effect: 3.03 <= OR <= 5.31, 0.01 <= p(interaction) <= 0.03).

156 east cancer with ERCC6 (main effect: 1.29 <= OR <= 2.91, 0.005 <= p <= 0.04, 11.8 <= MAF <= 40.9%), a

157 e lowest quintiles of alpha-2-macroglobulin (OR = 3.71, CI = 1.21-11.33), ferritin (OR = 4.20, CI = 1

158 s of visual acuity recovery and maintenance (OR: 1.13; 95% CI: 1.03-1.27; Q = 0.031).

159 had higher odds of death compared to males (OR = 1.26, 95% CI 1.21-1.30).

160 R = 1.53 [95% CI = 1.09 to 2.14]; for males, OR = 1.42 [95% CI = 1.02 to 1.99]).

161 bidopsis OR, genetically mimicking the melon OR(His) allele, and found that it also constrains chromo

162 sociated with disorders of lipid metabolism (OR 1.22, 95% CI 1.12-1.34) and ischaemic heart disease (

163 tion with several CVD outcomes including MI (OR = 1.84, 95% CI, 1.43, 2.37, P value = 2.0 x 10-6), CH

164 .0001), and surgeries exceeding 30 minutes (OR = 1.21, 95% CI = 1.17-1.25).

165 1.03-1.30) and alpha-fetoprotein < 20 ng/mL (OR, 1.90; 95% CI, 1.12-3.21).

166 ated with poorer visuospatial scores, MNDbi (OR=3.14, 95% CI 1.09 to 8.99) and MND-FTD (OR=5.08, 95%

167 associated with increased 30-day mortality (OR, 8.4 [95% confidence interval, 2.23-31.7]).

168 .41, P < .001; OR, 2.07, P < .001) and MSP1 (OR, 2.41, P = .0006; OR, 5.78, P < .001), respectively.

169 sequence of conformational changes in the mu-OR and G(i) system and for exploring the path that leads

170 riving after 11 years of age showed a myopia OR of 0.65 (95% confidence interval [CI], 0.63-0.67; P <

171 nificantly with both myopia and high myopia (OR, 2.43 and 2.31).

172 ), through octarepeat and nonoctarepeat (non-OR) binding sites.

173 es and by one water molecule, making the non-OR region more exposed to the solvent.

174 ub-analysis of night-only shift work nurses (OR = 1.12, 95% CI = 1.03-1.21).

175 ange was associated with decreased SGA odds (OR = 0.35, 95% CI: 0.19, 0.64).

176 ct evidence for the spontaneous formation of OR dimers in living cells under physiological conditions

177 aded with plant-based oregano essential oil (OR) and trans-cinnamaldehyde (TCA) was studied.

178 4.20, CI = 1.40-12.65), and serum amyloid P (OR = 3.05, CI = 1.16-8.01) were associated with odds of

179 09) and to not experience pain on palpation (OR = 6.278; P = 0.007).

180 (OR = 34.6, 95% CI 11.3-106.5) or paralysis (OR = 19.0, 95% CI 4.8-74.8) and when the dog was dead at

181 of 63 [68%] versus 31 of 63 [49%] patients; OR, 2.1; 95% CI, 1.5 to 2.7; P=0.008).

182 m 1.03 to 10.05) and moderate periodontitis (OR(adjusted) ranged from 1.96 to 2.51; 95% CI ranged fro

183 To examine the role of peripheral ORs in triggering brain hypoxia, we used oxygen sensors

184 17753641) is strongly associated with PFAPA (OR 2.13, P = 6 x 10(-9)).

185 95% CI, 0.18-0.61), sphingosine-1-phosphate (OR(1SD): 0.60; 95% CI: 0.40-0.89), and apolipoprotein A-

186 (OR, 8.3 [95% CI, 4.4-15.9]; AFE, 88%), PIV (OR, not available; AFE, approximately 100%), HMPV (OR, 9

187 (OR 11.19, 95% CI: 2.09-60.02) or pneumonia (OR 5.37, 95% CI: 1.17-24.65), any adverse event (OR 1.55

188 tion (OR = 5.71(1.58-7.12)), HIV positivity (OR = 2.22(1.32-3.73)) and living in a more rural area (O

189 SOT recipients (7.3%), and exposure to PPIs (OR 2.4, 95% CI 1.1-5.4) and third-generation cephalospor

190 ing prescriptions from multiple prescribers (OR 0.80, 95% CI 0.68-0.95).

191 ntly associated with fovea-off presentation (OR, 1.47, 95% CI, 1.24-1.74, P < 0.001) and non-White ra

192 lut* OR GLX) AND (schizophrenia OR psychosis OR schizophren*).

193 grams, 95% CI: -54, -17), but not with PTB (OR = 1.03, 95% CI: 0.91, 1.18).

194 I, 1.24-1.74, P < 0.001) and non-White race (OR, 1.72, 95% CI, 1.27-2.39, P < 0.001).

195 , 95% CI: 0.41, 0.95), and perceived racism (OR: 0.61; 95% CI: 0.40, 0.92) were associated with lower

196 5% C.I. 1.00-1.13, p<0.05), basal heart rate(OR 1.07, 95% C.I. 1.02-1.13, p<0.01) and dual antiviral

197 2 [95%CI 1.32-1.99]), waist-to-height ratio (OR = 1.74 [1.39-2.17]) and total skinfolds (OR = 2.02 [1

198 her prevalence of periodontitis (Odds ratio (OR) (highest vs. lowest quartile of FLI),1.63; 95% confi

199 o difference between study arms [odds ratio (OR) 0.96 (0.74-1.25)].

200 ciated with increased morbidity [odds ratio (OR) 1.2, P = 0.004], but not readmission (OR 1.1, P = 0.

201 <=30%: 32.1% vs FLR >30%: 28.6%; odds ratio (OR) 1.22, 95% CI 0.46-3.27) or major complication rates

202 tients to be referred to the ED [odds ratio (OR) 1.32, 95% confidence interval (CI) 1.09-1.60].

203 as not associated with ALL risk (odds ratio (OR) = 0.85, 95% confidence interval (CI): 0.60, 1.21).

204 ated with increased odds of LBW [odds ratio (OR) = 1.40, 95% confidence interval (CI): 1.14, 1.71] an

205 up showed a significantly higher odds ratio (OR) for DM in men aged 64 years or younger (OR [95% conf

206 regression model calculated the odds ratio (OR) for SCAD among patients with a history of autoimmune

207 Data were pooled as odds ratio (OR) or mean difference (MD) with a random-effects model.

208 The odds ratio (OR) per interquartile range (IQR) increase [9,200 partic

209 n pathology include tobacco use (odds ratio (OR), 2.0; 95% confidence interval (CI), 1.2-3.4, P = 0.0

210 th increased risk of macrosomia (odds ratio [OR] 1.38, 95% CI 1.01-1.89, p = 0.04) versus neonates of

211 5 in the control group; adjusted odds ratio [OR] 1.74, 95% CI 0.81-3.74).

212 Frisen grade >=3 (odds ratio [OR] 10.21, P < .0053) and cases with worsening papillede

213 GVHD prophylaxis group (adjusted odds ratio [OR] 3.49 [95% CI 1.60-7.60]; p=0.0016).

214 every day a challenge (adjusted odds ratio [OR] 3.81, 95% confidence interval [CI] 2.49 to 5.86) and

215 ints from week 4 to 8 (P = .004, odds ratio [OR] 31.3, 95% confidence interval [CI] 3.0 to 329) and c

216 having a diagnosis of melanoma (odds ratio [OR] 5.01; 95% Confidence Interval [CI] 3.50-7.61) and ki

217 of preparing dinner at home (Q4 odds ratio [OR] = 0.3 [95% CI 0.1-0.9]; P = 0.03) relative to the lo

218 the PRSs for total cholesterol (odds ratio [OR] = 0.92; 95% confidence interval [CI] = 0.85-0.99; p

219 risks of sensitization to birch (odds ratio [OR] = 1.12 [95% CI = 1.01-1.25] per 10-mug/m(3) increase

220 lower rate of sICH (vs 0-3 days; odds ratio [OR] = 1.49, 95% confidence interval [CI] = 0.50-4.43), n

221 emographic/medical history, BMI (Odds Ratio [OR] = 1.62 [95%CI 1.32-1.99]), waist-to-height ratio (OR

222 final logistic model were: MetS (odds ratio [OR] = 2.02; P = 0.003), number of teeth <=14 (OR = 1.78;

223 pathogenic variants in the CFH (odds ratio [OR] = 2.88; P = 0.006), CFI (OR = 4.45; P = 0.005), and

224 dicating a worse condition (with odds ratio [OR] greater than 1.00 favouring the control group).

225 ical hamartoma-related features (odds ratio [OR] range of 4.1-102.9).

226 ing follow-up, opioid injecting (odds ratio [OR], 0.95; 95% confidence interval [CI], 0.92-0.99) and

227 ated with larger tumor diameter (odds ratio [OR], 1.15, 95% confidence interval [CI], 1.03-1.30) and

228 test (stress: 14.6% versus 8.5%, odds ratio [OR], 1.91; CTA: 36.5% versus 8.4%, OR, 5.95; P<0.001) an

229 alarial antibody levels to AMA1 (odds ratio [OR], 2.41, P < .001; OR, 2.07, P < .001) and MSP1 (OR, 2

230 versus 37 of 63 [59%] patients; odds ratio [OR], 2.7; 95% confidence interval [95% CI], 1.6 to 3.8;

231 rated neoplastic transformation (odds ratio [OR], 3.729; 95% confidence interval [CI], 1.099-12.649;

232 ptomatic children with diabetes (odds ratio [OR], 6.5; P = 0.01), a recent contact (OR, 2.3; P = 0.02

233 uded pre-existing renal disease (odds ratio [OR], 7.4; 95% CI, 2.5-22.0), oxygen requirement at hospi

234 er adjustment, medical mistrust (odds ratio [OR]: 0.59; 95% confidence interval [CI]: 0.39, 0.91), ex

235 field recovery and maintenance (odds ratio [OR]: 1.26; 95% confidence interval [CI]: 1.12-1.41; Q <

236 (for females, 19.8% versus 4.7% [odds ratio {OR} = 5.05; 95% confidence interval {CI} = 3.01 to 8.46]

237 f pain at rest [EHS I vs EHS II: odds ratio, OR = 1.350 (1.180-1.543), P < 0.001; EHS I vs EHS III an

238 Odds ratios (OR) with 95% confidence intervals (CI) for sarcopenia we

239 Conditional logistic regression odds ratios (ORs) accounting for individual matching on sex and birth

240 The odds ratios (ORs) per 1-SD increase of log-transformed alcoholic drin

241 Odds ratios (ORs) were calculated as part of the logistic regression

242 etection rates and age-adjusted odds ratios (ORs) were calculated.

243 Individual survey odds ratios (ORs) were pooled using random-effects meta-analysis.

244 Odds ratios (ORs) with 95% confidence intervals (CIs) were determined

245 ogistic regression to calculate odds ratios (ORs).

246 o (OR) 1.2, P = 0.004], but not readmission (OR 1.1, P = 0.48) or LOS (incidence rate ratio 1.0, P =

247 sed likelihood of withdrawal for any reason (OR 2.61, 95% CI: 1.38-4.96) or due to adverse events (OR

248 nction via knockout of the odorant receptor (OR) co-receptor, Orco, results in drastic AL reductions

249 atterns of responses from odorant receptors (ORs), trace-amine associated receptors (TAARs), or both.

250 ic data was highly predictive of recurrence (OR 13.20, P = 0.0197).

251 CI = 1.12-6.32), and acute graft rejection (OR = 3.01; 95% CI = 1.78-5.09).

252 , 1.50; 95% CI, 1.29 to 1.74), reoperations (OR, 1.74; 95% CI, 1.42 to 2.14), and length of hospital

253 dogs, was inversely associated with AD risk (OR = 0.40; P-value = .004).

254 ersus < 1 times/day) or overall cancer risk (OR 0.93; 95% CI 0.75-1.16; P = 0.52 for >= 2 versus < 1

255 egion associated with NMO, led by rs9272219 (OR = 2.48, P = 8 x 10(-10)).

256 ence of possible causal attribution for RSV (OR, 8.5 [95% CI, 3.9-18.5]; AFE, 88%), Flu (OR, 8.3 [95%

257 not available; AFE, approximately 100%), RV (OR, 7.1 [95% CI, 3.7-13.6]; AFE, 86%) and CoV (OR, 2.8 [

258 lutamate OR glut* OR GLX) AND (schizophrenia OR psychosis OR schizophren*).

259 P < 0.001; EHS II vs EHS III and/or scrotal: OR = 1.363 (1.125-1.650), P = 0.002], pain on exertion [

260 P < 0.001; EHS II vs EHS III and/or scrotal: OR = 1.414 (1.121-1.783), P = 0.003] at 1-year follow-up

261 P < 0.001; EHS II vs EHS III and/or scrotal: OR = 1.492 (1.296; 1.717), P < 0.001], and pain requirin

262 P < 0.001; EHS I vs EHS III and/or scrotal: OR = 1.839 (1.504-2.249), P < 0.001; EHS II vs EHS III a

263 P < 0.001; EHS I vs EHS III and/or scrotal: OR = 2.002 (1.727-2.321), P < 0.001; EHS II vs EHS III a

264 P < 0.001; EHS I vs EHS III and/or scrotal: OR = 2.254 (1.774-2.865), P < 0.001; EHS II vs EHS III a

265 e (OR 2.23, 95% CI: 1.07-4.64) and sedation (OR 4.21, 95% CI: 1.18-15.01).

266 igher risk developing allergic sensitization(OR [95% CI] = 2.00 [1.04:3.86] at age 4; 2.35 [1.20:4.63

267 sociated with higher odds of seroconversion (OR 4.3, 95% CI 1.2-14.9, p=0.02).

268 a positive association between both severe (OR(adjusted) ranged from 2.21 to 3.92; 95% CI ranged fro

269 nfidence interval (CI): 1.14, 1.71] and SGA (OR = 1.22, 95% CI: 1.02, 1.45), and decreased tBW (mean

270 dence interval [CI], 0.92-0.99) and sharing (OR, 0.87; 95% CI, 0.80-0.94) decreased, whereas no signi

271 nd APOE epsilon4 status was not significant (OR: 1.04, 95% CI: 0.97, 1.11).

272 den in RNA-binding-protein regulatory sites (OR = 1.13, 95% CI 1.1-1.2, P = 8.8 x 10(-5)).

273 (OR = 1.74 [1.39-2.17]) and total skinfolds (OR = 2.02 [1.60-2.55]) showed the strongest associations

274 th <=14 (OR = 1.78; P = 0.034), and smoking (OR = 2.19; P = 0.001).

275 ea (OR 2.61, 95% CI: 1.46-4.67), somnolence (OR 2.23, 95% CI: 1.07-4.64) and sedation (OR 4.21, 95% C

276 earch terms (magnetic resonance spectroscopy OR MRS) AND (glutamate OR glut* OR GLX) AND (schizophren

277 d regulatory T cells was associated with ST (OR = 2.89, 95% CI 1.03-8.16, P = .045).

278 Standardizing OR to ICU handoffs significantly improved information ex

279 ated with lower risk of small vessel stroke (OR: 0.82, 95% CI = 0.75-0.89) and lower WMH volume (beta

280 89; 95% CI, 1.01-8.27 for diabetic subgroup; OR (highest vs. lowest quartile of FLI), 1.45; 95% CI, 1

281 eatment with LT, including cataract surgery (OR, 0.31; 95% CI, 0.30-0.32), corneal transplantation (O

282 .39; 95% CI, 0.31-0.49), and retina surgery (OR, 0.46; 95% CI, 0.41-0.51).

283 .3; P = 0.02), and testing for surveillance (OR, 2.7; P = 0.005) had higher estimated risks of having

284 es were more likely to not exhibit swelling (OR = 9.35; P = 0.009) and to not experience pain on palp

285 iated with increased likelihood of symptoms (OR: 3.91, 95%CI: 1.55-9.87).

286 ts related to abnormal liver function tests (OR 11.19, 95% CI: 2.09-60.02) or pneumonia (OR 5.37, 95%

287 The OR with 95%CI for Q4 was 1.44(1.18, 1.76), Q1 as a refer

288 stment but remained strong; for example, the OR after adjustment for confounders for low educational

289 We found that the ORs for VTE increased across GDF-15 quartiles (Ptrend =

290 and third-generation cephalosporin therapy (OR 3.9, 95% CI 1.4-10.5) were identified as risk factors

291 .02-1.13, p<0.01) and dual antiviral therapy(OR 12.46, 95% C.I. 2.09-74.20, p<0.1) were independent p

292 At last follow-up, eyes that returned to OR and control eyes were similar in terms of mean intrao

293 Also, transfer (OR = 2.17, CI95%[1.814; 2.709], P < 0.001) and especiall

294 95% CI, 0.30-0.32), corneal transplantation (OR, 0.39; 95% CI, 0.31-0.49), and retina surgery (OR, 0.

295 f CD (OR = 1.22, 95% CI: 1.01, 1.49) and UC (OR = 1.15, 95% CI: 1.02, 1.30) than childless men.

296 Medical graduate status outside of the US (OR: 0.58; 99% CI: 0.36-0.93; P < .001) was associated wi

297 OR, 0.98; 95% CI, 0.94-1.02) or alcohol use (OR, 0.99; 95% CI, 0.95-1.04).

298 creatic fistula (OR-3.84), and epidural use (OR-3.12) were independently associated with zero last-24

299 igh HDL oxidative-inflammatory index values (OR(1SD), 1.53; 95% CI, 1.01-2.33) and low apolipoprotein

300 less likely to reengage in care than women (OR: 0.39; 95% CI: 0.22-0.67; p-value: 0.001).

301 s more frequently than construction workers (OR 4.15, 95% CI 2.52, 6.85).

302 (OR) for DM in men aged 64 years or younger (OR [95% confidence interval (CI)], 1.71 [1.03-2.85]; P-v